Drugs / active vitamin D
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT07381998 | Jan 2026 → Jul 2027 expected | secondary hypoparathyroidism due to impaired parathormon secretion | Aarhus University Hospital | Enrolling by invitation | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02915705 Comparator | Sep 2016 → Feb 2018 | X-linked hypophosphatemic rickets | Kyowa Kirin, Inc. | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | active vitamin D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07381998 ↗ |
| Route | Oral | “tablet, oral solution” NCT02915705 ↗ |